Hematology

Latest News

Axi-Cel Shows Efficacy in Patients With R/R LBCL Ineligible for ASCT
Axi-Cel Shows Efficacy in Patients With R/R LBCL Ineligible for ASCT

September 28th 2023

Around half of patients with R/R large B-cell lymphoma are considered ineligible for autologous stem cell transplant and are thus ineligible for the approved indication of Yescarta.

Around the Helix: Cell and Gene Therapy Company Updates – September 27, 2023
Around the Helix: Cell and Gene Therapy Company Updates – September 27, 2023

September 27th 2023

Mesoblast Gears Up for Third Push for Remestemcel-L's Approval in GvHD
Mesoblast Gears Up for Third Push for Remestemcel-L's Approval in GvHD

September 22nd 2023

Research Identifies Cell Signatures of CAR T-Cells in Long Remission
Research Identifies Cell Signatures of CAR T-Cells in Long Remission

September 21st 2023

Around the Helix: Cell and Gene Therapy Company Updates – September 20, 2023
Around the Helix: Cell and Gene Therapy Company Updates – September 20, 2023

September 20th 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.